New Method Of Treatment Glaucoma

New Method Of Treatment Glaucoma.
Contact lenses that direct glaucoma medication over elongate periods are getting closer to reality, say researchers working with laboratory animals. In their study, the lenses delivered the glaucoma knock out latanoprost (brand name Xalatan) continuously to animals for a month. It's hoped that some epoch such lenses will replace eye drops now occupied to treat the eye disease, the researchers said Dec 2013.

And "In general, liking drops are an inefficient method of drug delivery that has notoriously poor patient adherence," look lead author Dr Joseph Ciolino, a cornea specialist at the Massachusetts Eye and Ear Infirmary, said in an first-aid station news release. "This contact lens form can potentially be used as a treatment for glaucoma and as a platform for other eye drug delivery applications". Glaucoma is the important cause of irreversible blindness worldwide.

The lenses, which appeared safe in cell culture and coarse studies, are the first to be shown to release drugs for this long in animals, according to the researchers. The study appears online and in the January linocut issue of the journal Biomaterials. The lens the research pair developed "is capable of delivering large amounts of drug at substantially constant rates over weeks to months," Daniel Kohane, numero uno of the Laboratory for Biomaterials and Drug Delivery at Boston Children's Hospital, said in the rumour release going here. Ciolino said a noninvasive method of incessant eye-drug delivery could save millions of people from blindness if it helps them comply with their medication regimen.